financetom
SLGN
financetom
/
Consumer Discretionary
/
SLGN
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Silgan Holdings Inc.SLGN
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Silgan Holdings Inc., together with its subsidiaries, manufactures and sells rigid packaging solutions for consumer goods products in the United States and internationally.

It operates through three segments: Dispensing and Specialty Closures, Metal Containers, and Custom Containers.

The Dispensing and Specialty Closures segment offers a range of metal and plastic closures, and dispensing systems for food, beverage, health care, garden, home, personal care, and beauty products, as well as capping/sealing equipment and detection systems.

The Metal Containers segment manufactures and sells steel and aluminum containers for food products, such as pet food, vegetables, soups, proteins, tomato based products, fruits, and other miscellaneous food products, as well as general line metal containers primarily for chemicals.

The Custom Containers segment manufactures and sells custom designed and stock plastic containers for use in personal care and health care; food and beverage; household and industrial chemical; pharmaceutical; pet food and care; agricultural; automotive; and marine chemical products.

This segment also provides plastic thermoformed barrier and non-barrier bowls, and trays for food products, such as soups, other ready-to-eat meals, and pet food products; and plastic closures, caps, sifters, and fitments, as well as thermoformed tubs for food, household, and personal care products.

The company markets its products primarily through direct sales force, as well as through a network of distributors, and an online shopping catalog.

The company was founded in 1987 and is headquartered in Stamford, Connecticut.

Latest News >
Haleon to sell nicotine replacement therapy business outside US for $633 mln
Haleon to sell nicotine replacement therapy business outside US for $633 mln
Jun 26, 2024
June 26 (Reuters) - Haleon ( HLN ) will sell its nicotine replacement therapy business outside the U.S. to a unit of India's Dr. Reddy's for 500 million pounds ($632.55 million), the British consumer healthcare company said on Wednesday. The divestment is expected to dilute Haleon's ( HLN ) 2024 net revenue and adjusted operating profit by about 0.5% and...
CrowdStrike Holdings Hits $1 Billion in Sales with CDW
CrowdStrike Holdings Hits $1 Billion in Sales with CDW
Jun 26, 2024
08:46 AM EDT, 06/26/2024 (MT Newswires) -- CrowdStrike Holdings ( CRWD ) said Wednesday it had surpassed $1 billion in total sales over the lifetime of its partnership with CDW (CDW). The company also said it has achieved CDW's Diamond Level Partner status. The partnership allows the companies to leverage CrowdStrike's ( CRWD ) Falcon platform in delivering advanced cybersecurity...
Visa Launches Digital Card Replacement Service
Visa Launches Digital Card Replacement Service
Jun 26, 2024
08:46 AM EDT, 06/26/2024 (MT Newswires) -- Visa (V) said Wednesday it launched its digital emergency card replacement service that promptly delivers a digital card replacement through text or email on behalf of card issuers. The company said cardholders can authenticate the emergency card replacement and add it to their digital wallet as soon as they receive it. Price: 273.00,...
Medicenna Secures European Approval for Phase 1/2 ABILITY-1 Study to Europe
Medicenna Secures European Approval for Phase 1/2 ABILITY-1 Study to Europe
Jun 26, 2024
08:45 AM EDT, 06/26/2024 (MT Newswires) -- Medicenna Therapeutics ( MDNAF ) on Wednesday said the European Medicines Agency (EMA) approved its clinical trial application to conduct the Phase 1/2 ABILITY-1 Study with lead candidate MDNA11 either alone or in combination with pembrolizumab. The ABILITY-1 trial is currently enrolling patients at clinical trial sites in the U.S., Canada, Australia, and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved